🇺🇸 FDA
Patent

US 11173147

Prophylactic or therapeutic agent for delirium

granted A61KA61K31/423A61K31/428

Quick answer

US patent 11173147 (Prophylactic or therapeutic agent for delirium) held by Takeda Pharmaceutical Company Limited expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/423, A61K31/428, A61K31/4439, A61P